 | Up a level |
Turco, F; Smith, M; Omlin, A; Gillessen, S (2022). Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.02.010. European urology, 82(1), e13. Elsevier 10.1016/j.eururo.2022.03.029
von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mjhic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R; Swiss Group for Clinical Cancer Research, (SAKK) (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of oncology, 23(2), pp. 531-6. Oxford: Oxford University Press 10.1093/annonc/mdr126
von Rohr, L; Klaeser, B; Joerger, M; Kluckert, T; Cerny, T; Gillessen, S (2007). Increased pulmonary FDG uptake in bleomycin-associated pneumonitis. Onkologie, 30(6), pp. 320-3. Basel: Karger 10.1159/000101517
